http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0100210-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 1998-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fabb2913c57578b7f1d80e41e39ddf73 |
| publicationDate | 2001-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-0100210-A2 |
| titleOfInvention | 11 Beta-substituted 19-nor-steroids, process for their preparation, intermediates and pharmaceutical compositions containing such compounds |
| abstract | The present invention relates to compounds of formula (I) and their addition salts with bases or fatty acids, wherein the main substituents are: R1 is hydrogen, (CH2) m-Ar, (CO) -Ar, (CH2) m-Alk or (CO). -Alk group; R2 is a saturated, unsaturated, straight or branched chain hydrocarbon having from 1 to 6 carbon atoms; D is a 5-membered or 6-membered ring optionally substituted and optionally unsaturated; X is halogen or hydrogen; and n is 3, 4 or 5; R3 and R4 are independently hydrogen, (CH2) m-Ar, (CH2) m-Het or (CH2) m-Alk, or R3 and R4 together with the nitrogen to which they are attached are aromatic or non-aromatic, saturated or unsaturated, a monocyclic or multicyclic heterocyclic group; Ar is a C 6 -C 18 carbocyclic aryl group; Het is a saturated or unsaturated, aromatic or non-aromatic heterocyclic group containing from 1 to 9 carbon atoms and from 1 to 5 heteroatoms; Alk is a non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon group having from 1 to 12 carbon atoms; and m is 0, 1, 2 or 3. The invention also relates to the preparation of compounds of the above and to pharmaceutical compositions and intermediates containing such compounds. HE |
| priorityDate | 1997-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.